The Ministry of health has specified the rules of regulation of prices for medicines: the new rules will come into force on October 1

The Ministry of Health of Belarus has adjusted the procedure for establishing and applying regulated prices for medicines. The relevant changes are provided for by the resolution of the department of September 17, 2026 No. 102, published on the National Legal Internet Portal.

Amendments were made to the resolution of the Ministry of Health of March 6, 2012 No. 13 – one of the paragraphs of the Instruction on the procedure for establishing and applying regulated prices was adjusted. Now organizations set selling prices independently, but not above the maximum limit approved by Resolution No. 101 of September 17, 2026.

Document No. 101 defines the maximum selling prices for drugs of various groups: antiparasitic, dermatological, anti-infectious, antitumor and immunomodulatory, drugs for the respiratory system, gastrointestinal tract and metabolism, blood and hematopoietic organs, the nervous system, as well as for the treatment of diseases of the sense organs.

The list includes drugs from such manufacturers as "Belmedpreparaty", "Pharmland", "Belaseptic", "Reb-pharma", "Pharmtechnologiya", Borisov and Nesvizh plants of medical preparations, "Akademfarm", Bobruisk plant of biotechnology and "Ferain".

In addition, limit prices for oxygen - gaseous and liquid. The price of gaseous oxygen includes the cost of filling the cylinder, loading and unloading operations on the territory of the manufacturer and temporary use of the balloon by the consumer.

Resolution No. 102 enters into force on October 1, 2026. At the same time, they were recognized as invalid by the Ministry of Health of October 24, 2025 No. 165 and No. 8 of February 9, 2026.

Photo: pixabay, illustrative in nature